In vitro activity and function of B7-H4-Ig fusion protein


B7-H4 has been shown to inhibit T cell proliferation, cytokine production and cell cycle in vitro. B7-H4 deficient mice develop exacerbated disease in the mouse models of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D) and Experimental Autoimmune Encephalomyelitis (EAE). On the other hand, B7-H4-Ig fusion protein has been documented to assuage the symptoms in mouse models of RA, T1D, and multiple sclerosis in vivo. In the present study, B7-H4-Ig bound to the majority of human peripheral blood monocytes and NK cells, but not to either normal or activated T cells. B7-H4-Ig fusion protein was assayed for its effects in allogeneic mixed lymphocyte culture (MLC) systems. Soluble B7- H4-Ig had no significant effect in the MLC, but with a tendency to promote allogeneic response. Immobilized, but not soluble B7-H4-Ig inhibited plastic bound anti-CD3 mediated activation of T cells. This inhibition however was largely due to B7-H4-Ig mediated displacement of anti-CD3 antibody from the plastic plate. Finally, B7-H4-Ig had no effect on the cytotoxicity mediated by NK and LAK cells in PBMC. Our findings thus caution against the interpretation of suppressive effect observed solely in plate-bound anti-CD3 mediated T cell co-stimulation in vitro.

Share and Cite:

Rasmussen, S. , Kosicki, M. , Svendsen, S. , Claesson, M. and Kristensen, N. (2013) In vitro activity and function of B7-H4-Ig fusion protein. Open Journal of Immunology, 3, 24-32. doi: 10.4236/oji.2013.31004.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Prasad, D.V.R., Richards, S., Mai, X.M. and Dong, C. (2003) B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity, 18, 863-873. doi:10.1016/S1074-7613(03)00147-X
[2] Sica, G.L., Choi, I.H., Zhu, G.F., Tamada, et al. (2003) B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity, 18, 849-861. doi:10.1016/S1074-7613(03)00152-3
[3] Zang, X., Loke, P., Kim, J., Murphy, K., Waitz, R. and Allison, J.P. (2003) B7x: A widely expressed B7 family member that inhibits T cell activation. Proceedings of the National Academy of Sciences, 100, 10388-10392. doi:10.1073/pnas.1434299100
[4] Mao, Y.X., Chen, Y.J., Ge, Y., Ma, H.B., et al. (2006) Recombinant human B7-H4 expressed in Escherichia coli inhibits T lymphocyte proliferation and IL-2 secretion in vitro. Acta pharmacologica Sinica, 27, 741-746. doi:10.1111/j.1745-7254.2006.00338.x
[5] Kryczek, I., Wei, S., Zou, L., Zhu, G., et al. (2006) Cutting edge: Induction of B7-H4 on APCs through IL-10: Novel suppressive mode for regulatory T cells. Journal of Immunology, 177, 40-44.
[6] Choi, I.H., Zhu, G., Sica, G.L., Strome, S.E., Cheville, J.C., Lau, J.S., Zhu, Y., Flies, D. B., Tamada, K. and Chen, L. (2003) Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. Journal of Immunology, 171, 4650-4654.
[7] Chinnadurai, R. and Grakoui, A. (2010) B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells. Hepatology, 52, 2177-2185. doi:10.1002/hep.23953
[8] Chen, Y., Yang, C., Xie, Z., Zou, L., Ruan, Z., Zhang, X., Tang, Y., Fei, L., Jia, Z. and Wu, Y. (2006) Expression of the novel co-stimulatory molecule B7-H4 by renal tubular epithelial cells. Kidney International, 70, 2092-2099.
[9] Zou, W. and Chen, L. (2008) Inhibitory B7-family molecules in the tumour microenvironment. Nature Reviews, Immunology, 8, 467-477. doi:10.1038/nri2326
[10] Kryczek I., Zou L., Rodriguez P., Zhu, G. et al. (2006) B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. Journal Experimental Medicine, 203, 871-881. doi:10.1084/jem.20050930
[11] Azuma T., Zhu G.F., Xu H.Y., Rietz A.C., et al. (2009) Potential Role of Decoy B7-H4 in the Pathogenesis of Rheumatoid Arthritis: A Mouse Model Informed by Clinical Data. Plos Medicine, 6, Article ID: e1000166. doi:10.1371/journal.pmed.1000166
[12] Wei J., Loke P., Zang X. and Allison J.P. (2011) Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity. Journal Experimental Medicine, 208, 1683-1694. doi:10.1084/jem.20100639
[13] Wang X. Hao J., Metzger D.L., Mui A., et al. (2011) Early treatment of NOD mice with B7-H4 reduces the incidence of autoimmune diabetes. Diabetes, 60, 3246-3255. doi:10.2337/db11-0375
[14] Chen L. (2004) Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nature Reviews Immunology, 4, 336-347. doi:10.1038/nri1349
[15] Geisler C., Plesner T., Pallesen G., Skj?dt et al. (1988) Characterization and expression of the human T cell receptor-T3 complex by monoclonal antibody F101.01. Scandinavian Journal of Immunology, 27, 685-696. doi:10.1111/j.1365-3083.1988.tb02402.x
[16] Wang X., Hao J., Metzger D.L., Ao Z., et al. (2012) B7-H4 treatment of T cells inhibits ERK, JNK, p38, and AKT Activation. PloS One, 7, Article ID: e28232. doi:10.1371/journal.pone.0028232
[17] Suh W.K., Wang S., Duncan G.S., Miyazaki Y., Mak, T.W., et al. (2006) Generation and characterization of B7-H4/B7S1/ B7x-deficient mice. Molecular and Cellular Biology, 26, 6403-6411. doi:10.1128/MCB.00755-06

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.